Phathom Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for gastrointestinal diseases. The company develops its products based on vonozopran, an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. Its products under development include VOQUEZNA, which has completed its Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD) and its Phase II clinical trials for the as-needed dosing for active heartburn episodes; and VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK, which have completed the Phase III clinical trials for the eradication of Helicobacter pylori infection. The company has the rights in the United States, Europe, and Canada for P-CAB. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [05/29/2026 15:52 PDT] Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT), Down By 100% ($11.39) From $11.39 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [05/29/2026 08:16 PDT] PHAT SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [05/29/2026 06:40 PDT] PHAT Expected to Trade Down Short Term
• [05/19/2026 07:22 PDT] PHAT Expected to Trade Down After Bearish Patterns Develop
• [05/19/2026 06:34 PDT] sector Stocks Expected To Be Down After Top Correlated Stocks Fire Sell Signals.
• [05/14/2026 15:33 PDT] Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT), Up By 100% ($11.7) From $11.7 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [05/06/2026 07:45 PDT] PHAT Expected to Trade Up After Bullish Patterns Develop
• [05/05/2026 07:09 PDT] PHAT Expected to Trade Up After Bullish Patterns Develop
• [04/30/2026 10:29 PDT] Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT), Down By 100% ($12.16) From $12.16 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [04/27/2026 06:51 PDT] sector Stocks Expected To Be Up After Top Correlated Stocks Fire Buy Signals.
• [04/24/2026 04:23 PDT] PHAT Expected to Trade Down After Bearish Patterns Develop
• [04/22/2026 09:51 PDT] Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT), Up By 100% ($10.52) After BUYINS.NET SqueezeTrigger Report Released on Wednesday, March 25th 2026 at a Price of $10.52.
• [04/14/2026 09:25 PDT] PHAT Expected to Trade Up After Bullish Patterns Develop
• [04/09/2026 13:58 PDT] Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT), Up By 100% ($10.57) From $10.57 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [04/07/2026 07:13 PDT] PHAT Expected to Trade Down After Bearish Patterns Develop
• [04/07/2026 06:49 PDT] PHAT Expected to Trade Down Short Term